Ultragenyx Pharmaceutical, Inc. (RARE)
22.75
+0.12
(+0.53%)
USD |
NASDAQ |
Jan 21, 16:00
23.01
+0.26
(+1.14%)
After-Hours: 07:32
Ultragenyx Pharmaceutical Free Cash Flow: -466.39M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Corcept Therapeutics, Inc. | 162.57M |
| Johnson & Johnson | 20.46B |
| CorMedix, Inc. | 74.42M |
| Amicus Therapeutics, Inc. | 9.691M |
| Geron Corp. | -132.68M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -91.42M |
| Cash from Investing (Quarterly) | 117.18M |
| Cash from Financing (Quarterly) | 0.002M |
| Free Cash Flow Per Share (Quarterly) | -0.9291 |
| Free Cash Flow to Equity (Quarterly) | -72.91M |
| Free Cash Flow to Firm (Quarterly) | -78.48M |
| Free Cash Flow Yield | -21.02% |